Orchestra BioMed Holdings CEO David Hochman's 2023 pay jumps 119% to $6.9M
Orchestra BioMed Holdings reports 2023 executive compensation
By ExecPay News
Published: April 30, 2024
Orchestra BioMed Holdings reported fiscal year 2023 executive compensation information on April 30, 2024.
In 2023, three executives at Orchestra BioMed Holdings received on average a compensation package of $5.2M, a 67% increase compared to previous year.
Average pay of disclosed executives at Orchestra BioMed Holdings
David P. Hochman, Chief Executive Officer, received $6.9M in total, which increased by 119% compared to 2022. 50% of Hochman's compensation, or $3.5M, was in stock awards. Hochman also received $347K in non-equity incentive plan, $2.5M in option awards, as well as $595K in salary.
Darren R. Sherman, Chief Operating Officer, received a compensation package of $6.4M, which increased by 106% compared to previous year. 62% of the compensation package, or $4M, was in stock awards.
Andrew L. Taylor, Chief Financial Officer, earned $2.4M in 2023.
Related executives
You may also like
Source: SEC filing on April 30, 2024.